Pharmaceutical News

RSS

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

A study in Obstetrics & Gynecology finds that antenatal COVID-19 vaccination does not increase the risk of adverse pregnancy outcomes, confirming vaccine safety for pregnant women.

12 Jun 2024

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

Three University of North Florida (UNF) researchers have been awarded a U.S. patent for a targeted cancer-fighting compound, or peptoid, that the team has discovered targets certain breast, colon and lung cancers and stops them from progressing.

12 Jun 2024

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced the publication of a peer reviewed study in the Journal of Cystic Fibrosis1.

12 Jun 2024

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Short-term adverse effects of COVID-19 mRNA vaccinations are linked to higher and longer-lasting neutralizing antibody responses, indicating robust immune efficacy.

11 Jun 2024

New PREVENT risk equations could reduce statin use by 40%, study finds

If national guidelines are revised to incorporate a new risk equation, about 40% fewer people could meet criteria for cholesterol-lowering statins to prevent heart disease, according to a study by researchers at the University of Pittsburgh, Beth Israel Deaconess Medical Center and University of Michigan.

10 Jun 2024

Injectable fish oil emulsion reduces brain damage in newborn rodents

An injectable emulsion containing two omega-3 fatty acids found in fish oil markedly reduced brain damage in newborn rodents after a disruption in the flow of oxygen to the brain near birth, a study by researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

6 Jun 2024

U.S. cardiovascular disease costs set to skyrocket by 2050, new study reveals

New research forecasts that the economic burden of cardiovascular disease and stroke in the U.S. will nearly quadruple by 2050, highlighting the urgent need for preventive measures.

5 Jun 2024

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm.

5 Jun 2024

Discovery of antibiotic lolamicin that targets deadly bacteria without harming gut microbiome

Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.

4 Jun 2024

Unflagged vaccine-skeptical content on Facebook causes significant vaccine hesitancy, study finds

A recent study in Science reveals that unflagged vaccine-skeptical content on Facebook significantly reduces COVID-19 vaccination intentions. This highlights the urgent need for better misinformation interventions.

3 Jun 2024

Low-dose aspirin can reduce inflammatory responses to sleep restriction

A new study to be presented at the SLEEP 2024 annual meeting found that low-dose acetylsalicylic acid, also known as aspirin, can reduce inflammatory responses to sleep restriction.

3 Jun 2024

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass., and published in the journal Thyroid.

3 Jun 2024

Long-term study reveals safety of metformin use during pregnancy

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Two diabetes medications more beneficial in preventing major cardiovascular events

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Insurance denials hinder GLP1Ra use in children and teens with type 2 diabetes

Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Weight loss drug may change how obese people perceive taste

Semaglutide improved taste sensitivity, changed gene expression in the tongue that's responsible for taste perception, and changed the brain's response to sweet tastes, according to research presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Progesterone therapy shows mixed results for neurodevelopment in infants with heart defects

A randomized clinical trial published in JAMA Network Open found no significant overall benefit of maternal progesterone therapy on neurodevelopmental outcomes in infants with congenital heart defects, but observed improvements in female children and specific heart conditions.

2 Jun 2024

Community pharmacists deliver cheaper, quality care for minor ailments, study shows

A recent study in ClinicoEconomics and Outcomes Research found that community pharmacists can provide high-quality, cost-effective care for minor ailments, reducing the financial burden on the healthcare system compared to primary care physicians, urgent care, and emergency departments.

2 Jun 2024

Previous
1
...
14
15
16
17
18
19
20
...
1433
Next

Pharmaceutical News

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

UNF researchers awarded U.S. patent for targeted cancer-fighting compound

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

New PREVENT risk equations could reduce statin use by 40%, study finds

Injectable fish oil emulsion reduces brain damage in newborn rodents

U.S. cardiovascular disease costs set to skyrocket by 2050, new study reveals

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

Discovery of antibiotic lolamicin that targets deadly bacteria without harming gut microbiome

Unflagged vaccine-skeptical content on Facebook causes significant vaccine hesitancy, study finds

Low-dose aspirin can reduce inflammatory responses to sleep restriction

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Long-term study reveals safety of metformin use during pregnancy

Two diabetes medications more beneficial in preventing major cardiovascular events

Insurance denials hinder GLP1Ra use in children and teens with type 2 diabetes

Weight loss drug may change how obese people perceive taste

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Progesterone therapy shows mixed results for neurodevelopment in infants with heart defects

Community pharmacists deliver cheaper, quality care for minor ailments, study shows

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News